FilingPulse

CDTX insider transaction filings

Cidara Therapeutics, Inc. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-09. Screen CDTX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-01-094RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner		Option exercise (M): 1,286,786 @ $0.00 · Disposition to issuer (D): 4,652,309 @ $221.50 · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 5,079 (derivative) · Option exercise (M): 1,286,786 (derivative) · Disposition to issuer (D): 89,956 (derivative) @ $15,505EDGAR
2026-01-074Davarpanah Nicole Negar — Chief Medical OfficerDisposition to issuer (D): 12,553 @ $221.50 · Disposition to issuer (D): 8,333 · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 62,597 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +1 moreEDGAR
2026-01-074Merson James — DirectorDisposition to issuer (D): 4,250 (derivative) · Disposition to issuer (D): 2,125 (derivative) · Disposition to issuer (D): 11,100 (derivative)EDGAR
2026-01-074Canale-Theakston Carin — DirectorDisposition to issuer (D): 1,750 (derivative) · Disposition to issuer (D): 875 (derivative) · Disposition to issuer (D): 1,400 (derivative) · Disposition to issuer (D): 2,125 (derivative) · Disposition to issuer (D): 2,125 (derivative) · Disposition to issuer (D): 16,000 (derivative) · +1 moreEDGAR
2026-01-074Spencer Ryan — DirectorDisposition to issuer (D): 4,250 (derivative) · Disposition to issuer (D): 2,125 (derivative) · Disposition to issuer (D): 11,100 (derivative)EDGAR
2026-01-074Resnick Joshua — DirectorDisposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 5,079 (derivative)EDGAR
2026-01-074Bassler Bonnie L — DirectorDisposition to issuer (D): 15 @ $221.50 · Disposition to issuer (D): 1,750 (derivative) · Disposition to issuer (D): 875 (derivative) · Disposition to issuer (D): 1,400 (derivative) · Disposition to issuer (D): 2,125 (derivative) · Disposition to issuer (D): 2,125 (derivative) · +2 moreEDGAR
2026-01-074Ward Shane — COO & CLODisposition to issuer (D): 25,083 @ $221.50 · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 6,207 (derivative) · Disposition to issuer (D): 12,499 (derivative) · Disposition to issuer (D): 135,540 (derivative) · Disposition to issuer (D): 50,000 (derivative)EDGAR
2026-01-074Mineo Chrysa — DirectorDisposition to issuer (D): 3,320 @ $221.50 · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 875 (derivative) · Disposition to issuer (D): 875 (derivative) · +5 moreEDGAR
2026-01-074Stein Jeffrey — President & CEO, DirectorDisposition to issuer (D): 5,763 @ $221.50 · Disposition to issuer (D): 2,379 @ $221.50 · Disposition to issuer (D): 67,498 @ $221.50 · Disposition to issuer (D): 7,949 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,749 (derivative) · +8 moreEDGAR
2026-01-074Stein Jeffrey — President & CEO, DirectorOther (J): 270 · Other (J): 645 @ $155 · Purchase (P): 645 @ $155 · Other (J): 750 @ $118.95 · Purchase (P): 750 @ $118.95 · Other (J): 367 @ $135.80 · +6 moreEDGAR
2026-01-074Schroeder Theodore R — DirectorDisposition to issuer (D): 450 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 875 (derivative) · Disposition to issuer (D): 875 (derivative) · +5 moreEDGAR
2026-01-074KARBE FRANK — Chief Financial OfficerDisposition to issuer (D): 7,526 @ $221.50 · Disposition to issuer (D): 43,125 · Disposition to issuer (D): 115,000 (derivative)EDGAR
2026-01-074BURGESS DANIEL D — DirectorDisposition to issuer (D): 150 @ $221.50 · Disposition to issuer (D): 450 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 875 (derivative) · +6 moreEDGAR
2025-12-294Davarpanah Nicole Negar — Chief Medical OfficerGift (G): 450 @ $0EDGAR
2025-12-294Stein Jeffrey — President & CEO, DirectorGift (G): 33,072 @ $0 · Gift (G): 33,072 @ $0 · Gift (G): 2,244 @ $0 · Gift (G): 2,244 @ $0 · Gift (G): 10,638 @ $0 · Gift (G): 10,638 @ $0 · +1 moreEDGAR
2025-12-124Ward Shane — COO & CLOTax withholding (F): 15,041 @ $219.60 · Option exercise (M): 3,500 @ $16.65 · Option exercise (M): 6,459 @ $20.20 · Sale (S): 9,959 @ $220.08 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 6,459 (derivative) @ $0EDGAR
2025-12-124Davarpanah Nicole Negar — Chief Medical OfficerTax withholding (F): 10,332 @ $219.60EDGAR
2025-12-124Stein Jeffrey — President & CEO, DirectorTax withholding (F): 2,285 @ $219.60EDGAR
2025-12-124KARBE FRANK — Chief Financial OfficerTax withholding (F): 7,290 @ $219.60EDGAR
2025-09-154Davarpanah Nicole Negar — Chief Medical OfficerSale (S): 474 @ $62.86EDGAR
2025-06-304RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner		Purchase (P): 2,272,727 @ $44EDGAR
2025-06-184Resnick Joshua — DirectorGrant/award (A): 5,079 (derivative) @ $0EDGAR
2025-06-184Spencer Ryan — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184Merson James — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184Canale-Theakston Carin — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184Bassler Bonnie L — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184Mineo Chrysa — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184Schroeder Theodore R — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-184RA CAPITAL MANAGEMENT, L.P. — Director
RA Capital Healthcare Fund LP — Director
Kolchinsky Peter — Director
Shah Rajeev M. — Director		Grant/award (A): 5,079 (derivative) @ $0EDGAR
2025-06-184BURGESS DANIEL D — DirectorGrant/award (A): 11,100 (derivative) @ $0EDGAR
2025-06-044Mineo Chrysa — DirectorPurchase (P): 2,270 @ $21.71 · Purchase (P): 1,050 @ $23.44EDGAR
2025-05-124Davarpanah Nicole Negar — Chief Medical OfficerGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-04-024Ward Shane — COO & CLOGrant/award (A): 25,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-04-024Stein Jeffrey — President & CEO, DirectorGrant/award (A): 275,000 (derivative) @ $0EDGAR
2025-03-134Ward Shane — COO & CLOSale (S): 1,664 @ $21.96EDGAR
2025-03-134Tari Leslie — CHIEF SCIENTIFIC OFFICERSale (S): 1,773 @ $21.96EDGAR
2025-02-264KARBE FRANK — Chief Financial OfficerGrant/award (A): 57,500 @ $0 · Grant/award (A): 115,000 (derivative) @ $0EDGAR

Recent 8-K events — Cidara Therapeutics, Inc.

FiledFormItems reportedSource
2026-01-078-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-148-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-10-068-K1.01 — Entry into a Material Definitive AgreementEDGAR
2025-09-248-K8.01 — Other EventsEDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-248-K8.01 — Other EventsEDGAR
2025-06-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CDTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →